Search

The role of the human beta-defensin 1 (hBD-1) in the susceptibility to the onset of the Atypical Squamous Cells of Undetermined Significance (ASCUS) lesion, in the presence or not of HPV infection, is still unknown. In the current study, the three functional single nucleotide polymorphisms (SNPs) -52G A, -44C G, and -20G A at the 5' un-translated region (UTR) of DEFB1 gene, encoding hBD-1, were analyzed in ASCUS lesion gynecological patients and healthy women from the north-east of Italy (Trieste). Cervical samples from 249 European-Caucasian women were collected, screened for HPV and cytologically evaluated; DEFB1 genotyping has been performed by direct sequencing. No significant differences were found for -52G A, -44C G, and -20G A SNPs allele and genotype frequencies between women with and without ASCUS lesions. DEFB1 minor haplotypes were significantly more frequent in ASCUS lesion positive than negative women, associating with an increased risk of this type of lesion. When women were stratified according to HPV infection status, significant differences in the distribution of -52G A SNP genotype frequencies were found: the presence of the A allele in the homozygous genotype A/A associated with a lower risk of developing ASCUS lesions in HPV negative women. DEFB1 minor haplotypes were also associated with an increased risk of developing ASCUS lesions, being significantly more frequent in HPV negative women with lesions, than without lesions. Although these results highlight the possible involvement of DEFB1, further studies are needed to support the role of DEFB1 in the modulation of the susceptibility to ASCUS lesions.

We investigated the association between MBL2 gene exon 1 functional polymorphisms and autoimmune thyroid disease (AITD) in 163 Brazilian patients (87 with Hashimoto thyroiditis, HT; 76 with Graves' disease) and 214 healthy controls. Individuals carrying MBL2 O allele are at higher risk of developing AITD (OR = 1.58, 95\% CI: 1.11-2.26; P-value = 0.009) and HT (OR = 1.67, 95\% CI: 1.09-2.55; P-value = 0.013) as suggesting a possible role for mannose-binding lectin in influencing disease susceptibility.

Τα τελευταία χρόνια, ανοσολογικές διεργασίες άσηπτης φλεγμονής έχουν αναγνωρισθεί ότι συμμετέχουν τόσο στην πρόκληση, όσο και στην (πρώιμη ή όψιμη) έκβαση των ισχαιμικών αγγειακών εγκεφαλικών επεισοδίων (Ι-ΑΕΕ). Στην παρούσα μελέτη ελέγχθηκε κατά πόσον η γενετική προδιάθεση, προς εντονότερη (ή ασθενέστερη) ανοσολογική απάντηση, θα μπορούσε να προβλέπει το οξύ Ι-ΑΕΕ, τη νευρολογική του εξέλιξη, την 6μηνη έκβασή του και την ανάπτυξη κοινών νευροψυχιατρικών επιπλοκών (κατάθλιψη, νοητική έκπτωση). Για το σκοπό αυτό αναλύθηκε η πιθανή προγνωστική αξία 5 σημειακών λειτουργικών πολυμορφισμών στα γονίδια φλεγμονωδών κυτταροκινών (IL4-589C>T, IL10-1082G>A, TNFa-308G>A, IL6-174G>C και IL12B 1188A>C) σε 145 διαδοχικούς ασθενείς με οξύ Ι-ΑΕΕ και ισάριθμους μάρτυρες. Επιπρόσθετα, η μελέτη αξιολόγησε το ρόλο της αντιφλεγμονώδους κυτταροκίνης αντιπονεκτίνης στην οξεία φάση του Ι-ΑΕΕ, καθώς και την πιθανή προβλεπτική της αξία στη νευρολογική του εξέλιξη, την πρόγνωση και την 6μηνη έκβασή του. Τα κύρια αποτελέσματα της μελέτης μπορούν να συνοψισθούν ως εξής: - Σε έναν ομογενή Eλληνικό πληθυσμό, οι λευτουργικοί πολυμορφισμοί IL4-589C>T, IL10-1082G>A, TNFa-308G>A, IL6-174G>C και IL12B 1188A>C δεν προβλέπουν την επέλευση ενός Ι-ΑΕΕ, την ηλικία έναρξης της νόσου ή την ανάπτυξη κατάθλιψης και νοητικής έκπτωσης όψιμα μετά το Ι-ΑΕΕ. - Ο IL4-589CT γονότυπος σχετίστηκε με την τάση της νόσου για υποτροπή. - Ο IL10-1082GG αρχέγονος γονότυπος προέβλεπε την πρώϊμη νευρολογική επιδείνωση και τη χειρότερη λειτουργική του έκβαση 1ου και 3ου μήνα. - Ο TNFa-308GG αρχέγονος γονότυπος συνέβαλλε ευεργετικά στην καλύτερη λειτουργική έκβαση κατά τον 6ο μήνα. - Ο IL12B 1188AC ετεροζυγώτης προέβλεπε σημαντικά τα ελαφρύτερα Ι-ΑΕΕ και στη χαμηλότερη θνητότητα από αυτά. - Τα αυξανόμενα επίπεδα αντιπονεκτίνης ορού σχετίζονται με μείωση των πιθανοτήτων για ένα Ι-ΑΕΕ, ανεξάρτητα από τους κλασσικούς παράγοντες κινδύνου. - Η αντιπονεκτίνη ορού βρίσκεται κατεσταλμένη στην οξεία φάση του Ι-ΑΕΕ, αλλά και 6 μήνες μετά. Τα χαμηλά της επίπεδα δεν αποτελούν αντίδραση οξείας φάσης, αλλά αντικατοπτρίζουν το σταθερό αντιφλεγμονώδη ρόλο της. - H αντιπονεκτίνης ορού οξείας φάσης μετά ένα Ι-ΑΕΕ δεν προβλέπει τη νευρολογική εξέλιξη και την 6μηνη έκβαση της νόσου στον άνθρωπο. Προτείνουμε ότι στο μέλλον η έγκαιρη ταυτοποίηση των γενετικά προδιατεθειμένων ατόμων για βαρύτερη νόσο και επιβαρυμένη έκβαση μετά ένα Ι-ΑΕΕ, θα επιτρέπει την αναγνώριση ομάδων ασθενών με τις μεγαλύτερες ανάγκες εντατικοποιημένης αποκατάστασης και βελτιστοποίησης των ιατρικών μας θεραπειών. Επιπρόσθετα, προτείνουμε ότι η αντιπονεκτίνη θα μπορούσε να αποτελεί ένα δυνητικό θεραπευτικό στόχο τροποποίησης του αγγειακού κινδύνου. Immune processes of aseptic inflammation have been recently recognized as key participants into both the occurrence and (early or late) outcome of an ischemic stroke (IS). The current study tested whether the genetic predisposition for an enhanced (or suppressed) immunological response, could be predicting the occurrence, neurological evolution, 6-month outcome, and two common neuropsychiatric complications (depression, cognitive impairment) of an IS. For this purpose, 5 functional single nucleotide polymorphisms in the genes of inflammatory cytokines (IL4-589C>T, IL10-1082G>A, TNFa-308G>A, IL6-174G>C and IL12B 1188A>C) were analyzed for their putative prognostic value in 145 consecutive acute IS patients and in an equal-sized control group. Moreover, the present study evaluated the role of an anti-inflammatory cytokine, adiponectin, into the acute phase of an IS, as well as its possible predicting value in the neurological evolution, prognosis and 6-month outcome of the ischemic event. The main results of this study may be summarized as follows: - In a homogenous Greek population, the functional polymorphisms IL4-589C>T, IL10-1082G>A, TNFa-308G>A, IL6-174G>C and IL12B 1188A>C do not predict IS occurrence, age of disease onset, or the development of late post-stroke depression and cognitive impairment. - The IL4-589CT mutant genotype was associated with relapsing IS. - The IL10-1082GG ancestral genotype significantly predicted early stroke pregression and worse functional outcome on months 1 and 3. - The TNFa-308GG ancestral genotype beneficially contributed into better 6-month functional outcome. - The IL12B 1188AC heterozygote significantly predicted milder strokes and decreased IS mortality. - Increasing serum adiponectin levels are associated with reduced odds for an IS, independently of common vascular risk factors. - Low serum adiponectin is present at the acute phase and 6 months after an IS. Suppressed adiponectin levels are not an effect of the acute-phase response, but reflect its solid anti-inflammatory role. - Acute post-stroke serum adiponectin does not predict neurological evolution and 6-month outcome of an IS in humans. We propose that early identification of genetically predisposed subjects, for a more severe disease and for a worse outcome, will allow in the future the recognition of those IS sufferers, who would most benefit from intensive rehabilitation programs, and optimization of our medical therapies. Moreover, we propose that adiponectin may represent a promising candidate for the therapeutic risk modification of common vascular complications.

Background Linkage and congenic strain analyses using the nonobese diabetic (NOD) mouse as a model for human type 1 autoimmune diabetes (T1D) have identified several NOD mouse Idd (insulin dependent diabetes) loci, including Slc11a1 (formerly known as Nramp1). Genetic variants in the orthologous region encompassing SLC11A1 in human chromosome 2q35 have been reported to be associated with various immune-related diseases including T1D. Here, we have conducted association analysis of this candidate gene region, and then investigated potential correlations between the most T1D-associated variant and RNA expression of the SLC11A1 gene and its splice isoform. Methods Nine SNPs (rs2276631, rs2279015, rs1809231, rs1059823, rs17235409 (D543N), rs17235416 (3'UTR), rs3731865 (INT4), rs7573065 (-237 C→T) and rs4674297) were genotyped using TaqMan genotyping assays and the polymorphic promoter microsatellite (GT)n was genotyped using PCR and fragment length analysis. A maximum of 8,863 T1D British cases and 10,841 British controls, all of white European descent, were used to test association using logistic regression. A maximum of 5,696 T1D families were also tested for association using the transmission/disequilibrium test (TDT). We considered P ≤ 0.005 as evidence of association given that we tested nine variants in total. Upon identification of the most T1D-associated variant, we investigated the correlation between its genotype and SLC11A1 expression overall or with splice isoform ratio using 42 PAXgene whole blood samples from healthy donors by quantitative PCR (qPCR). Results Using the case-control collection, rs3731865 (INT4) was identified to be the variant most associated with T1D (P = 1.55 × 10-6). There was also some evidence of association at rs4674297 (P = 1.57 × 10-4). No evidence of disease association was obtained at any of the loci using the family collections (PTDT ≥ 0.13). We also did not observe a correlation between rs3731865 genotypes and SLC11A1 expression overall or with splice isoform expression. Conclusion We conclude that rs3731685 (INT4) in the SLC11A1 gene may be associated with T1D susceptibility in the European ancestry population studied. We did not observe a difference in SLC11A1 expression at the RNA level based on the genotypes of rs3731865 in whole blood samples. However, a potential correlation cannot be ruled out in purified cell subsets especially monocytes or macrophages.

Contains fulltext : 80760.pdf (Publisher’s version ) (Closed access) Ficolins are pattern-recognition molecules that appear to be relevant for innate immune defence against infections. The ficolin genes in Caucasians are polymorphic and genetic variations may have functional consequences, both in relation to function and concentration. Low levels of Ficolin-2 have been suggested to associate with recurrent respiratory tract infections (RTI), whereas data on Ficolin-3 are still very limited. We investigated the association between variation in genes encoding Ficolin-2 (FCN2) and Ficolin-3 (FCN3) and frequency of RTI during the first 4 years of life. The study population consisted of 900 children from a large, population-based birth cohort of Dutch children, followed prospectively from birth to 4 years of age. The number of RTI was assessed by annual parental questionnaires. Nine single nucleotide polymorphisms in FCN2 and two in FCN3, all based on functionality or haplotype-tagging characteristics, were determined and haplotypes constructed. We found that single nucleotide polymorphisms in FCN2 and FCN3 were not associated with increased risk of RTI during the first 4 years of life. No difference existed between haplotype-frequencies of FCN2 and FCN3 in children grouped according to the reported number of RTI. In conclusion, at a population level, genetic variation in ficolin genes FCN2 and FCN3 do not seem to contribute to the risk of RTI in Caucasian children.

Objective—Functional polymorphisms contributing to coagulation factor levels are preferential markers for association studies aimed at identifying prothrombic genetic components.Methods and Results—Factor V (FV) microsatellite genotypes were found to be associated with FV levels (P=0.003). Single nucleotide polymorphisms analysis and sequencing of the promoter and of coding regions identified two polymorphisms (Met2120Thr, Asp2194Gly) present in 20% of the population (n=1013) that are responsible for genotype-phenotype associations. The effect of the Met2120Thr polymorphism, both in plasma (mean reduction of FV level in the heterozygous condition: 25%) and in recombinant FV studies (34% reduction), was comparable to that of the Asp2194Gly change (20% and 34%, respectively). The study of 10 subjects with a rare genotype indicated that the Asp2194Gly substitution is the functional determinant of the reduced FV levels associated with the FVHR2 haplotype. Among Leiden carriers, the doubly heterozygous condition for FV2120Thr was found to be associated with a significantly increased activated protein-C resistance (APCR) (PP=0.009) in symptomatic than in asymptomatic subjects.Conclusions—Extensive analysis of FV polymorphisms indicated that changes in the C2 domain modulate FV levels and might increase APCR and thrombotic risk in FV Leiden carriers through a pseudohomozygous mechanism.

The control of coagulation factor levels has a pivotal role in thrombophilia and known functional polymorphisms explain only a minor part of the coagulation factor level variance. Several studies provide evidence for i) interaction of polymorphisms and their combination with environmental factors; ii) molecular mechanisms mediating activation of coagulation proteins by environmental factors; iii) molecular mechanisms mediating transcriptional control of thrombophilia genes by environmental factors. However, the vast majority of molecular regulation by environmental factors is still unknown. Understanding of gene-gene and gene-environment interactions will require a detailed knowledge of regulatory regions of thrombophilia genes and of regulatory proteins.